menu
    • menu

    Company profile for Strongbridge Biopharma

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are called Strongbridge for a reason. We're building a strong clinical and financial foundation to connect patients with new treatments for rare diseases. Focus. Commitment. Passion. That’s Strongbridge. Agile Clinical Development: Strongbridge is committed to bridging treatment gaps as rapidly as possible. We are building rare disease franchises that aim to utilize accelerated regulatory pathways when possible.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Strongbridge BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    900 Northbrook Drive, Suite 200 Trevose, PA 19053
    Telephone
    Telephone
    +1 610-254-9200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.strongbridgebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xeris scores FDA approval for rare disease med Recorlev
    Xeris scores FDA approval for rare disease med Recorlev

    01 Jan 2022

    // E. Sagonowsky FIERCEPHARMA

    https://www.fiercepharma.com/pharma/xeris-biopharma-scores-fda-approval-for-endogenous-cushing-s-syndrome-drug-recorlev

    E. Sagonowsky FIERCEPHARMA
    01 Jan 2022
    Share Share
    Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
    Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma

    05 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211005006055/en

    BUSINESSWIRE
    05 Oct 2021
    Share Share
    Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris
    Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris

    05 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/05/2309125/37274/en/Strongbridge-Biopharma-plc-Announces-Completion-of-Acquisition-by-Xeris-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    05 Oct 2021
    Share Share
    Strongbridge Announces Court Hearing Date ApproveProposed Acquisition by Xeris
    Strongbridge Announces Court Hearing Date ApproveProposed Acquisition by Xeris

    23 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/23/2302588/37274/en/Strongbridge-Biopharma-plc-Announces-Court-Hearing-Date-to-Approve-Proposed-Acquisition-by-Xeris-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    23 Sep 2021
    Share Share
    Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
    Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma

    14 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210914006023/en

    BUSINESSWIRE
    14 Sep 2021
    Share Share
    Strongbridge Announces Shareholder Approval of Proposed Acquisition by Xeris
    Strongbridge Announces Shareholder Approval of Proposed Acquisition by Xeris

    08 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/08/2293797/37274/en/Strongbridge-Biopharma-plc-Announces-Shareholder-Approval-of-Proposed-Acquisition-by-Xeris-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    08 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search